Search results

  1. E

    Opinion Towards a cure for long COVID: the strengthening case for persistently replicating SARS-CoV-2 as a driver of [PASC], 2024, Scoullar, Crabb+

    Just for completeness (not that it tells us much) there was also a small study without control group by Iwasaki on this subject Impact of COVID-19 vaccination on symptoms and immune phenotypes in vaccine-naïve individuals with Long COVID.
  2. E

    Why so little focus on Functional Disability and so much focus on “Symptoms”?

    I think hypotheses in medicine have to be able to consistently explain the majority of what is occuring and yield sufficiently good predictions but they don't have to explain the experience of every single person, especially not when there are outliers, different kinds of comorbidities or a...
  3. E

    The LIFT trial (OMF) - Pyridostigmine (mestinon) and Low Dose Naltrexone (LDN)

    Thanks! So it seems one can find it if one searches for "ME/CFS" but not when one searches for "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome" or "Myalgic Encephalomyelitis".
  4. E

    Long Covid drug BC-007 research news

    I suspect if the drug would have efficacy she would quote data from the outcome measures not some speculative correlation?
  5. E

    The LIFT trial (OMF) - Pyridostigmine (mestinon) and Low Dose Naltrexone (LDN)

    I searched for the trial on clinicaltrials.gov today and was unable to find it. I think it would be great if the OMF could upload their trial there so that other researchers, doctors as well as patients are aware of it and such that it becomes easier to track as well as understand which...
  6. E

    Professor Akiko Iwasaki and the Yale School of Medicine research on Long Covid and post infection syndromes

    Hey @Dakota15. I appreciate you digging up all these old news articles but am wandering whether you had any more specific goals in mind? Is it supposed to be a form of documentation and reminder what has been said over the years (I often find that studies I have long since forgotten about and...
  7. E

    Long Covid drug BC-007 research news

    From what I've heard from the people that are part of the trial in Erlangen, is that they are seemingly being told that the neutralizing effect of BC007 is high in comparison to placebo. If that was true it would suggest that the drug works as intended, without yielding any efficacy. I'm not...
  8. E

    Effects of a plank-based strength training programme on muscle activation in patients with long COVID: a case series, 2024, Navarro-Lopez et al

    Seems like an unwise study. The authors should have known: You have to plank and do the rubiks cube at the same time, only that can solve mind-body issues.
  9. E

    Preprint Long-term serum spike protein persistence but no correlation with post-COVID syndrome, 2024, Fehrer, Scheibenbogen+

    I think the crucial point may be that it is precisely such circumstantial evidence that lead people down the viral persistence route in the first place and thus far none of this evidence has stood the test of time (Simoa, Paxlovid etc were all the initial motivators and subsequent studies have...
  10. E

    PolyBio Fall 2024 Symposium

    Seems like all the Polybio projects from phase 1 are still ongoing (for example the numerous "microclot projects") or negative results aren't published or preprints aren't published, does anybody know?
  11. E

    Incompetence and “Useless” Research into ME and Long COVID

    Without any medical education myself, meaning this is all rather worthless blabbering, I wander whether this might not be quite an intrinsic problem in medical research that is often less apparent in some harder sciences (and possibly even more apparent in the softer ones such as sociology) that...
  12. E

    Preprint Long-term serum spike protein persistence but no correlation with post-COVID syndrome, 2024, Fehrer, Scheibenbogen+

    Interesting that they mention no relationship between spike protein concentration to time since last exposure. Could of course be very difficult to quantify as the correct description is likely "time since last known exposure", but I do think it contradicts some other results previously seen.
  13. E

    Blood Volume Deficit in POTS Assessed by Semi-Automated Carbon Monoxide Rebreathing, 2024, Kulapatana et al

    The problem is however, that the guidelines are not particularly specific, everybody is brewing their own cuppa and that previous research has appeared to be rather arbitrary and not particularly well matched and that the studies often lack data to asses them. In the analysis here the comparison...
  14. E

    Blood Volume Deficit in POTS Assessed by Semi-Automated Carbon Monoxide Rebreathing, 2024, Kulapatana et al

    I don't think that's a problem here. If the paper compares female POTS patients to female healthy controls (which they appear to be doing) then that is a sufficiently good control already. The male controls can then be viewed as an additional variable to gain further understanding (and it seems...
  15. E

    Impacts of the 2024 change in US government on ME/CFS and Long Covid

    As horribly grim as those news are, 600 out of 18,718 is not that much, it will depend on where they will be positioned and who the people leaving are. I am more worried by the quote "that half of NIH's research budget should be spent on "preventative, alternative and holistic" medicines."...
  16. E

    Netherlands: NKCV (Hans Knoop)

    I was thinking they maybe wouldn't have done so, they might have just given testimonials and the right of public usage of those without images (and possibly under false names). I think many people wouldn't want to have their picture together with health information open in the public. But I...
  17. E

    Netherlands: NKCV (Hans Knoop)

    To play devils advocate wouldn't it be possible for testimonials to be real but due to data-privacy regulations it not being possible to upload real pictures and names (hence stock pictures and fake names)?
  18. E

    Netherlands ZonMW Long Covid research grants 2024, including Rob Wüst on PEM

    Looks like several clinical trials are planned some of which are: immunadsorption (double blinded), Sonlicromanol (double blinded and placebo-controlled), Minocycline (double blinded and placebo-controlled), SSRI's, proof of concept study for IDO2 adressing medication, rTMS... That's quite...
  19. E

    Netherlands ZonMW Long Covid research grants 2024, including Rob Wüst on PEM

    Whilst the article itself seems to conflate PEM with anything exertion related, it is brillant to once again see that Rob Wüst has understood the difference and that they are not studying PEM, but rather that they are studying the response of muscles to exercise which may or may not have...
  20. E

    The Concept of ME/CFS, 2024, Edwards

    Would it be easier when answering a symptom questionnaire to also have a point system for impact of said symptom on daily functioning and how badly one would rate this symptom on a scale of 1 to 5? Might be a bit harder to directly deduce which symptom is "worse" from such a questionnaire, but...
Back
Top Bottom